Skip to content

Clinical trials

Phase 2 Pain trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pain Phase: Phase 2 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20193
20211
20222
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Jiangsu HengRui Medicine Co., Ltd.2
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2
Affiliated Cancer Hospital & Institute of Guangzhou Medical University1
Hubei Hospital of Traditional Chinese Medicine1
Jiangsu Aosaikang Pharmaceutical Co., Ltd.1
Navy General Hospital, Beijing1
Ping Yang1
Second Affiliated Hospital of Wenzhou Medical University1
Shijiazhuang Yiling Pharmaceutical Co. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pain14
Osteoarthritis2
Agnosia1
Colic1
Diabetes Mellitus1
Musculoskeletal Diseases1
Nasopharyngeal Carcinoma1
Neuralgia1
Nutrition Disorders1
Osteoarthritis, Knee1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.